Plain-English translation of NCT07517432 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท
This trial is an international registry โ essentially a large database โ that tracks patients with gastric cancer who have robot-assisted minimally invasive gastrectomy, a newer surgical approach where the surgeon uses robotic tools to remove part or all of the stomach through very small incisions. Researchers want to collect real-world data on how well this robotic approach works compared to traditional open surgery, including how patients recover, their quality of life afterward, and whether the cancer outcomes are just as good.
While robot-assisted minimally invasive surgery shows promise for reducing pain, shortening hospital stays, and improving recovery compared to traditional open surgery, there is still limited data on long-term outcomes and whether cancer survival rates are truly comparable. This registry aims to gather comprehensive information from centers around the world to better understand the true benefits and safety of this newer surgical approach for gastric cancer patients.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
As a participant, you would have your surgery at a participating hospital, and your medical team would collect and share your surgical and health data with the international registry โ both during your operation and as you recover. This is not a treatment study where you receive something new; rather, you are having the surgery your doctor already planned, and your outcomes are being tracked alongside other patients worldwide to help researchers learn more about this surgical approach. You may be asked follow-up questions about your recovery and quality of life after surgery as part of the registry.
AI-generated summary from trial data ยท Jun 24, 2026 ยท Not medical advice
Hong Kong